TxCell

Last News

June, 2010: TxCell announces the successfull completion of the Preclinical Development of TX-RAD in Inflammatory Arthritis

April, 2010: TxCell announces Positive Preliminary Results from the Phase I/IIa clinical trial of OvaSave in Crohn's Disease

January, 2010
: TxCell appoints Miguel Forte Chief Medical Officer

July, 2009
: The collaboration project with TxCell, TcLand, INSERM U844/CHRU Montpellier, has been approuved by the French Public Institutions for the development of Tr1 cell-based technology in Rheumatoid Arthritis and Juvenile Idiopathic Arthritis.

 More News


Newsroom Newsroom Products

 • June 15th 2010
TxCell announces the successfull completion of the Preclinical Development of TX-RAD in Inflammatory Arthritis
For more information, please click on flags 
English version or   French version   

 • April 29th 2010
TxCell announces Positive Preliminary Results
from the Phase I/IIa Clinical Trial of OvaSave in Crohn's Disease
For more information, please click on flags 
English version or   French version   

January 25th 2010
TxCell appoints Miguel Forte as Chief Medical Officer
For more information, please click on flags   English version  or   French version   


• September 4th 2008
TxCell appoints Marc D. Beer as Chairman of the Supervisory Board
For more information, please click on flags
  English version  or  French version

• March 5th 2008
TxCell completes a 10.5 million second round and initiates its first clinical trial
For more information, please click on flags
   English version  or  French version 

 

Spot Light

TxCell Science Video Click to Enlarge

A new TxCell publication
released in 2009

Learn More

AFA 2010




Copyright Txcell SA © 2008 - 2010 - All Rights Reserved - Legal Notice & Privacy Policy